Module XVIII -  New FDA Actions II

Tuesday June 1, 1999 - Question 8

Which of the following statements regarding orlistat (Xenical®) is correct?

A. Orlistat is a new drug approved to treat obesity.

B. Orlistat is a systemically acting lipase inhibitor.

C. The most common side effect of orlistat is constipation.

D. Orlistat can increase the absorption of fat-soluble vitamins.

E. The recommended dose of orlistat is one capsule at bedtime.
 
 

Discussion